MARRONE BIO INNOVATIONS INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
MARRONE BIO INNOVATIONS INC. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of -$1.00 million for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-05-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2022-05-09
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2021-06-30 was -$1.00M.
- MARRONE BIO INNOVATIONS INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2021 was -$1.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|
| 2021-12-31 | -$1.00M 10-K/A · filed 2022-05-09 | |
| 2021-06-30 | -$1.00M 10-Q · filed 2021-11-10 |